AVROBIO Inc.

NASDAQ: AVRO · Real-Time Price · USD
1.40
-0.02 (-1.41%)
At close: Jun 20, 2024, 10:00 PM

AVROBIO Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 617K 4.17M 1.4M
Gross Profit
n/a -617K -4.17M -1.4M
Operating Income
-58.02M -71.67M -105.43M -118.84M
Interest Income
4.26M 2.42M 299.00 n/a
Pretax Income
-57.98M 12.53M -105.89M -119.13M
Net Income
-57.98M 12.16M -106.05M -117.73M
Selling & General & Admin
16.65M 23.97M 33.25M 35.73M
Research & Development
41.36M 47.08M 72.19M 83.11M
Other Expenses
n/a n/a -456K -285K
Operating Expenses
58.02M 71.05M 105.43M 118.84M
Interest Expense
-107K 2.42M 299K n/a
Selling & Marketing Expenses
n/a 1.28M n/a n/a
Cost & Expenses
n/a 71.67M 105.43M 118.84M
Income Tax Expense
n/a 377K 157K -1.4M
Shares Outstanding (Basic)
8.49M 4.5M 43.74M 42.85M
Shares Outstanding (Diluted)
8.49M 4.46M 43.74M 42.85M
EPS (Basic)
-6.83 0.27 -2.42 -2.75
EPS (Diluted)
-6.83 0.27 -2.42 -2.75
EBITDA
-58.02M -71.05M -105.43M -118.84M
EBIT
n/a 14.95M -105.59M -119.35M
Depreciation & Amortization
n/a 617K 1.44M 1.4M